Kazushige Sakaguchi
Papers
16
Total Citations
85
H-Index
5
About
Kazushige Sakaguchi is a leading urologic oncologist whose research focuses on optimizing surgical and oncological outcomes for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). As a key member of the MSUG94 group, he has spearheaded large-scale, multicenter retrospective cohort studies across Japan that have reshaped clinical decision-making. His major contributions include demonstrating that pelvic lymphadenectomy may not improve biochemical recurrence-free survival, challenging standard practice, and developing a nomogram to predict lymph node involvement in the RARP era. He has also clarified the prognostic significance of positive surgical margin locations, lymphovascular invasion, and Grade Group 4 subgroups, providing nuanced risk stratification for patients. With several papers accumulating 10–15 citations each, his work has been instrumental in establishing evidence-based benchmarks for RARP in Japan. Notably, his research on hospital volume’s association with outcomes and the incidence of inguinal hernia post-surgery addresses critical perioperative and long-term care issues. Through these rigorous, collaborative studies, Sakaguchi has advanced the precision of prostate cancer surgery and postoperative management, making him a pivotal figure in contemporary urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10